新华制药
(000756)
| 流通市值：69.51亿 | | | 总市值：105.26亿 |
| 流通股本：4.56亿 | | | 总股本：6.90亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,158,318,911.44 | 996,332,270.24 | 922,054,214.18 | 918,334,462.29 |
| 应收票据及应收账款 | 981,148,228.56 | 1,033,782,443.1 | 1,070,639,818.39 | 708,069,058.14 |
| 其中：应收票据 | 9,731,035.63 | 11,120,887.78 | 11,055,799.68 | 8,191,109.23 |
| 应收账款 | 971,417,192.93 | 1,022,661,555.32 | 1,059,584,018.71 | 699,877,948.91 |
| 应收款项融资 | 107,579,010.69 | 265,906,217.22 | 218,826,544.83 | 240,274,709.86 |
| 预付款项 | 61,026,721.91 | 45,819,042.36 | 56,024,824.27 | 35,369,251.02 |
| 其他应收款合计 | 12,322,582.83 | 17,036,147.69 | 13,492,346.27 | 9,336,085.4 |
| 应收股利 | - | 8,182,200 | - | - |
| 存货 | 1,265,331,335.83 | 1,191,617,251.27 | 1,133,130,507.53 | 1,312,983,676.75 |
| 合同资产 | 657,211.26 | 678,211.26 | 489,429.4 | 819,429.4 |
| 其他流动资产 | 43,181,389.79 | 87,493,485.66 | 63,948,176.81 | 89,146,943.15 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,629,565,392.31 | 3,638,665,068.8 | 3,478,605,861.68 | 3,314,333,616.01 |
| 非流动资产: | | | | |
| 长期股权投资 | 58,789,469.55 | 59,906,504.83 | 59,760,826.16 | 58,572,098 |
| 其他权益工具投资 | 271,330,208.11 | 215,705,552.11 | 183,828,587.3 | 182,797,067.3 |
| 投资性房地产 | 32,594,764.39 | 33,411,820.38 | 33,123,436.97 | 33,908,633.73 |
| 固定资产 | 3,446,486,166.47 | 3,476,847,498.18 | 3,239,268,270.19 | 3,325,944,627.93 |
| 在建工程 | 772,568,081.63 | 671,137,450.24 | 828,515,767.09 | 730,545,057.96 |
| 使用权资产 | 1,655,952.41 | 3,386,775.98 | 4,187,942.53 | 4,324,321.34 |
| 无形资产 | 497,964,455.52 | 476,518,757.01 | 490,242,392.52 | 494,937,199.11 |
| 长期待摊费用 | 11,118,564.38 | 12,582,786.47 | 13,312,837.98 | 14,462,413.51 |
| 递延所得税资产 | 15,959,259.11 | 16,358,940.91 | 23,361,837.26 | 23,478,171.11 |
| 其他非流动资产 | 86,340,606.42 | 129,337,969.65 | 113,769,626.5 | 102,863,124.9 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 5,194,807,527.99 | 5,095,194,055.76 | 4,989,371,524.5 | 4,971,832,714.89 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 8,824,372,920.3 | 8,733,859,124.56 | 8,467,977,386.18 | 8,286,166,330.9 |
| 流动负债: | | | | |
| 短期借款 | 569,495,648.17 | 378,399,398.19 | 254,419,299.42 | 283,958,677.68 |
| 应付票据及应付账款 | 1,106,948,045.83 | 1,219,944,075.26 | 1,149,167,202.92 | 1,177,843,465.04 |
| 其中：应付票据 | 466,943,838.11 | 549,535,177.32 | 505,942,979.81 | 511,430,531.37 |
| 应付账款 | 640,004,207.72 | 670,408,897.94 | 643,224,223.11 | 666,412,933.67 |
| 合同负债 | 85,913,513.78 | 85,029,547.4 | 87,033,881.71 | 149,135,948.62 |
| 应付职工薪酬 | 44,556,875.97 | 45,175,159.34 | 91,274,467.36 | 123,985,296.73 |
| 应交税费 | 30,389,241.2 | 23,929,921.49 | 32,312,547.27 | 18,865,677.96 |
| 其他应付款合计 | 552,770,913.26 | 734,847,955.33 | 551,433,648.33 | 435,525,634.82 |
| 应付股利 | 14,292,599.53 | 184,894,508.28 | 5,310,599.53 | 15,290,599.53 |
| 一年内到期的非流动负债 | 296,197,899.94 | 110,571,244.26 | 262,783,929.95 | 273,755,184.03 |
| 其他流动负债 | 17,297,612.47 | 15,821,060.13 | 12,647,332.14 | 22,930,593.51 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,703,569,750.62 | 2,613,718,361.4 | 2,441,072,309.1 | 2,486,000,478.39 |
| 非流动负债: | | | | |
| 长期借款 | 791,040,739.2 | 912,190,889.2 | 796,700,000 | 799,400,000 |
| 租赁负债 | 391,884.16 | 1,164,135.29 | 1,685,593.91 | 1,578,792.87 |
| 长期应付款 | 21,500,000 | 21,500,000 | 21,500,000 | 20,000,000 |
| 递延收益 | 88,034,692.69 | 91,523,472.2 | 96,073,918.44 | 100,666,757.92 |
| 递延所得税负债 | 120,266,831.58 | 115,553,193.73 | 116,423,447.45 | 99,205,514.96 |
| 其他非流动负债 | 3,561,500 | 3,561,500 | 3,561,500 | 3,561,500 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,024,795,647.63 | 1,145,493,190.42 | 1,035,944,459.8 | 1,024,412,565.75 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 3,728,365,398.25 | 3,759,211,551.82 | 3,477,016,768.9 | 3,510,413,044.14 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 682,407,635 | 682,407,635 | 682,407,635 | 674,682,835 |
| 资本公积 | 1,131,062,026.76 | 1,122,731,950.76 | 1,114,401,874.76 | 1,055,010,870.76 |
| 其他综合收益 | 188,122,845.22 | 141,218,826.42 | 114,541,488.44 | 113,618,002.82 |
| 专项储备 | 6,997,065.49 | 6,505,475.15 | 5,288,601 | 3,392,612.67 |
| 盈余公积 | 400,960,654.39 | 400,960,654.39 | 400,960,654.39 | 400,960,654.39 |
| 未分配利润 | 2,461,856,744.96 | 2,400,241,402.85 | 2,447,318,331.54 | 2,305,438,893.92 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,871,406,971.82 | 4,754,065,944.57 | 4,764,918,585.13 | 4,553,103,869.56 |
| 少数股东权益 | 224,600,550.23 | 220,581,628.17 | 226,042,032.15 | 222,649,417.2 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,096,007,522.05 | 4,974,647,572.74 | 4,990,960,617.28 | 4,775,753,286.76 |
| 负债和股东权益合计 | 8,824,372,920.3 | 8,733,859,124.56 | 8,467,977,386.18 | 8,286,166,330.9 |
| 公告日期 | 2024-10-30 | 2024-08-23 | 2024-04-26 | 2024-03-29 |
| 审计意见(境内) | | | | 标准无保留意见 |